Henry Ford Hospital

This page highlights news and new technology from Henry Ford Hospital in Detroit, Michigan. The hospital is a luminary center and also a pioneer of new cardiovascular technologies and techniques in the areas of complex PCI, including chronic total occlusions (CTO) and transcatheter structural heart treatments, including transcatheter valve replacement (TAVR), transcatheter LAA occlusion and MitraClip mitral valve repair. The center has also been at the forefront of how to improve mortality in cardiogenic shock patients and heads the National Cardiogenic Shock Initiative

Impella, FDA, high risk PCI, abiomed

Abiomed's Impella 2.5 now has an FDA indication for high-risk PCI.

Technology | March 25, 2015
March 24, 2015 – The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) clearance for...
Adam Greenbaum, M.D., and William O'Neill, M.D., perform a TAVR procedure in a hybrid cath lab at Henry Ford Hospital in Detroit. Structural heart

Adam Greenbaum, M.D., and William O'Neill, M.D., perform a TAVR procedure in a hybrid cath lab at Henry Ford Hospital in Detroit.

Feature | February 17, 2015 | Lynn Tangorra
Transcatheter aortic valve replacement (TAVR) is not only a breakthough minimally invasive medical therapy, but offers...
transcaval aortic valve replacement, TAVR
Feature | December 23, 2014
December 23, 2014 — For patients transcatheter aortic valve replacement (TAVR) patients whose anatomy prevents the use...
boston scientific s-icd implantable cardioverter defibrillator ICD ep lab
News | January 17, 2014
January 17, 2014 — A new internal defibrillator that treats patients with major risk for sudden cardiac arrest is being...